Why is Morpho price up today?

Traders Union
All News
Crypto News
Morpho surges 12.16% today to $1.983

Highlights

Morpho raised $175 million in a funding round co-led by Paradigm, a16z Crypto, and Ribbit Capital, valuing the protocol at about $2 billion.
New capital will accelerate infrastructure buildout for on-chain credit and support global adoption among banks and asset managers.
MORPHO/USD shows strong intraday buyer momentum with a projected five-day range of $1.83 to $2.09 and a 75% probability of further upside.

Valuation jumps as major funding round signals institutional confidence

Morpho, a decentralized lending protocol, has secured $175 million in a major funding round co-led by Paradigm, a16z Crypto, and Ribbit Capital, with additional backing from institutional investors including Apollo Funds and Circle Ventures. This latest round values the protocol at approximately $2 billion and marks its fourth institutional fundraise since 2021. The capital is intended to support infrastructure expansion for on-chain credit markets and drive global adoption among banks and asset managers.

Anton Kharitonov, expert at Traders Union, sees underlying caution despite Morpho’s price rally. He notes that the asset trades just below the 20-day moving average while technical momentum remains mixed and trend signals lack real strength. Kharitonov is unimpressed by the recent funding news, pointing out that institutional investment does not guarantee sustainable price action. He highlights the weak ADX reading and potential downside if support at $1.83 is breached. "Traders should not mistake short-term spikes for a lasting uptrend — risk of reversal remains elevated."

Viktoras Karapetjanc, expert at Traders Union, interprets Morpho’s latest funding round as a confidence boost for the protocol’s global ambitions. He sees robust institutional support and a $2 billion valuation as strong tailwinds for adoption and liquidity inflow. Karapetjanc emphasizes that despite some technical hesitation, the bullish structure remains intact over the medium term. "With global institutions backing Morpho and key weekly indicators pointing up, I expect further growth and see this market offering multiple setups."

Parshwa Turakhiya, analyst, highlights Morpho’s intraday surge and elevated volatility as signs of lively short-term sentiment. He observes mixed oscillator readings but notes that buyer momentum remains strong with price near session highs. Turakhiya considers that the next few sessions hinge on whether bulls can break resistance near $2.09 or if momentum stalls below $1.83 support. "I see tactical trading opportunities here — bulls have the edge as long as volatility stays elevated and supports quick moves on either side."

Buyers dominate intraday as oscillators flag mixed momentum

Momentum signals are mixed: the Moving Average Convergence Divergence (MACD) on the daily timeframe shows a sell bias, but the Average Directional Index (ADX) value at 15.8 suggests weak trend strength. The Relative Strength Index (RSI) is neutral, while the Stochastic RSI and Commodity Channel Index (CCI) indicate neither strong overbought nor oversold conditions. Bull/Bear Power (BBP) shows buyers are dominating intraday momentum, supported by a strong buy signal. The asset advanced by $0.215 or 12.16% today, opening with an upside gap of about $0.13. Price is currently near the daily high, and intraday volatility stands at 5.48%, reflecting sustained strength toward the session highs. Oscillators signal a mixed picture, but intraday performance confirms strong buyer interest.

Earlier, analysts noted that Morpho exhibited strong bullish momentum driven by renewed market confidence and notable institutional backing. The current analysis strengthens this outlook, with sustained buyer interest suggesting upside potential toward $2.09 should resistance levels give way in the coming sessions.

Source of Data: MORPHO Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.